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The Lyt-2/Lyt-3 (Lyt-2/3)  glycoprotein complex is only expressed on the surfaces 
of particular subpopulations of thymus-derived (T) lymphocytes in the mouse. Among 
the cells that express Lyt-2/3 are the vast majority ofcytotoxic and suppressor T  cells, 
but relatively few of the helpers  (1,  2).  Recently, functional studies with monoclonal 
antibodies  against  Lyt-2 have suggested that  the Lyt-2/3 complex is associated with 
the antigen-binding structures on T  cells (3-5). Therefore, we have asked whether the 
Lyt-2 polypeptides made in nonclonal cell populations are heterogeneous, as expected 
for diverse antigen receptors, or uniform. We report here that the Lyt-2 glycoproteins 
are  subject  to  rapid  post-translational  processing,  but  that  the  newly  synthesized 
molecules are unique. 
Materials  and Methods 
Animals and Cells.  Inbred C57BL/6(B6), C57BL/6-Lyt-2.1 (B6-Lyt-2.1), and C57BL/6-Lyt- 
2.1 Lyt-3.1 (B6-Lyt2.1/3.1) mice (6) were bred in our colony at the Salk Institute. Thymocyte 
suspensions were prepared as described previously (7-9) from animals 3-6 wk old. 
Metabolic Labeling and Immune Precipitation.  Thymocytes were incubated with [aSS]methionine 
at 37°C as described previously (7, 8). In most experiments, Lyt-2/3 complexes were immuno- 
precipitated from detergent lysates of the labeled cells using the monoclonal antibody 19/178 
(3). Alternatively, the rat  monoclonal antibody 53.6.72  (10) was used with a goat anti-rat  Ig 
second-stage reagent. Conditions for preparation of lysates and immune precipitates, electro- 
phoresis in sodium dodecyl sulfate (SDS)  -containing gels, and fluorography were as.described 
previously (7-9,  11). In all cases, samples were analyzed under reducing conditions. 
Endoglycosidase H Digestion. After immunoprecipitation, samples were eluted from the Staphy- 
lococcus aureus immunoadsorbent  (Pansorbin;  Calbiochem-Behring Corp.,  American  Hoechst 
Corp.,  San  Diego,  CA)  and  incubated  with  endo-fl-N-acetylglucosaminidase  H  (endo  H) 
overnight  (7,  8),  using  3-10 p,g/ml  of endo  H  for complete  digestion.  Dr.  P.  W.  Robbins 
(Massachusetts Institute of Technology) donated the endo H. 
Two-dimensional Nonequilibrium pH Gradient Electrophoresis (NEPHGE) and SDS Gel Electrophore- 
sis.  First-dimension  NEPHGE electrophoresis  (12) was for 1,800 V-h in 4% polyacrylamide 
tube gels with  1.6% pH 5-7 ampholines and 0.4% pH 3.5-10 ampholines (LKB Instruments, 
Inc.,  Rockville,  MD).  Second-dimension  SDS  gel  electrophoresis  was carried  out  in  10.5% 
polyacrylamide gels. 
Results  and  Discussion 
Sizes  of Newly Synthesized Lyt-2/3  Glycoproteins.  Antibodies  against  either  Lyt-2 or 
Lyt-3 precipitate  similar  disulfide-linked  complexes of glycoproteins  (13-17).  These 
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can be dissociated into three types of components with apparent molecular weights of 
~30,000,  30,000-34,000,  and  35,000-38,000  (15-17).  This  heterogeneity  may result 
from differences in carbohydrate structure,  and so we have attempted to define the 
forms that the Lyt-2/3 glycoproteins display before extensive carbohydrate processing 
has taken place. 
To label  newly synthesized  proteins selectively, thymocytes were  incubated  with 
[3~S]methionine for 10 rain. The Lyt-2/3 molecules labeled in these cells migrated in 
SDS-polyacrylamide  gels  as  two  sharply-defined  species  with  apparent  molecular 
weights of 31,000  (31  K)  and 35,000  (35  K). To study the peptide moieties of these 
molecules, we digested pulse-labeled Lyt-2/3 immunoprecipitates with the glycosidase 
endo H. This enzyme selectively removes newly added carbohydrate from asparagine 
linkage  sites,  leaving only one sugar  residue  attached  to  the  polypeptide  (18,  19). 
Complete  endo  H  digestion  resulted  in  the  replacement  of the  31  K  and  35  K 
components by molecules with  apparent  molecular weights  of 20,000  (20  K)  and 
24,000-25,000  (24 K)  (Fig.  1 a, lane 3), which represent the maximum sizes for their 
polypeptide backbones. The specificity of the enzyme treatment was confirmed by its 
failure to alter the mobility of immunoglobulin ~ chains (cf. lanes 4 and 5), which are 
not glycosylated (20). 
High-Mannose Carbohydrate Chains in the Lyt-2/3 Complex.  To determine the number 
of carbohydrate chains associated with Lyt-2/3, we carried out partial digestions with 
limiting concentrations of endo H. The sizes of the resulting products are summarized 
in Table I. In this experiment, the Lyt-2/3 species showed slightly higher apparent 
sizes, relative to the markers, than they did in most cases, and the native 31 K  and 35 
K  species migrated as molecules of 32,000 and 36,000 dahons. With limited exposure 
to the enzyme, discrete digestion intermediates were generated with apparent masses 
of 28,000-29,000  daltons and 24,000 dahons. These disappeared when digestion was 
complete, leaving major end products of ~24 and 20 kilodahons  (Kd). This pattern 
indicated that a total of six carbohydrate chains could be removed from the two major 
glycoproteins, with a  shift of 3,500-4,000  in apparent molecular weight as each one 
was cleaved. 
Because the two major glycoproteins also differ in size by 4 Kd, it was difficult to 
separate their respective digestion intermediates. In several experiments, however, the 
relative labeling intensities suggested that the 24 K  endo H  product originated from 
the 35 K  component, while the 20 K  product was derived from the 31  K  component 
(data  not  shown).  This  suggests  that  each  component  carried  three  carbohydrate 
chains. 
Rapid Post-Translational Processing.  To compare the newly made glycoproteins with 
components of cell-surface Lyt-2/3 complexes, we traced the fate of the pulse-labeled 
molecules during a nonradioactive chase. After a  10-min labeling period, thymocytes 
were cultured in excess cold methionine for intervals from 20 min to 4 h  before they 
were  lysed.  As shown  in  Fig.  1 b,  the  molecules recognized  by anti-Lyt-2 changed 
rapidly in the course of the chase. 
Within  the first  20 min, a  new, heavily labeled  component appeared  in  the size 
range of 38-40  Kd.  This migrated as  a  heterogeneous  mixture of species  (Fig.  1 b, 
lane  2)  and  probably represents  the  38  Kd  cell-surface  form of Lyt-2 reported  by 
others (14-17). Once generated, this component was quantitatively stable throughout 
4 h  of chase (Fig.  1 b, lanes 2-5). In contrast, the pulse-labeled Lyt-2/3 species were 
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Fxc.  1.  Structural  analysis  and  post-translational  processing  of biosynthetically labeled Lyt-2/3 
complexes.  (a) Newly synthesized  Lyt-2/3 glycoproteins  before and after glycosidase treatment. Lyt- 
2/3 complexes synthesized  by pulse-labeled  B6 thymocytes (lanes 2, 3). Immunoglobulin molecules 
made by pulse-labeled  splenocytes  were precipitated with a rabbit anti-mouse Ig serum (lanes 4, 5). 
The samples  were mock digested  (lanes  2, 4) or digested to completion with endo H  (lanes  3, 5). 
Lane 1 is a normal mouse serum precipitate from the thymocyte lysate. Inputs of radioactive protein 
before precipitation were l0  s cpm for lanes  1-3 and 5 ×  105 cpm for lanes 4 and 5. Samples were 
fractionated  in  a  12.5% polyacrylamide  gel.  (b)  Kinetics  of processing  of Lyt-2/3  complexes. 
Thymocytes pulse labeled as in panel (a) were incubated in nonradioactive medium (chase) for the 
lengths of time indicated,  before  lysis. Lyt-2/3 complexes  were then  precipitated  from  samples 
containing 9 ×  l0  s cell equivalents of lysate. The inputs of radioactive protein decreased  from  1.3 
×  10  s cpm in the pulse-labeled  sample to 7.4 ×  105 cpm at 240 rain of chase. Samples were analysed 
by electrophoresis  in a  10.5% polyacrylamide gel. 
more  slowly  thereafter.  The  31  K  species  lost  radioactivity  throughout  the  chase, 
perhaps  giving rise to a  series of discrete degradation  products  that  appeared  in  the 
range of 28-30 kd. 
The dramatic appearance of the 38 kd form could indicate that a  new glycoprotein, 
itself unable  to  react  with  anti-Lyt-2  antibodies,  became  precipitable  when  it  was 
added to the complex 20 rain after it was made. However, the amount  of radioactivity 
specifically precipitated did not increase during the first 20 min of chase, as determined 
by  densitometric  scanning  of  the  31-38-kd  regions  of  the  original  autoradiogram 
(data not shown).  Therefore, it seems more likely that  all components  of the complex 
were  assembled  within  the  first  I0  min  of synthesis,  and  that  the  38-kd  molecules 
were  generated  from  the  35  K  or  31  K  forms  by  further  elaboration  of  their 368  ROTHENBERG  AND  TRIGLIA  BRIEF  DEFINITIVE  REPORT 
carbohydrate  structures.  This  processing is notably  more  rapid  than  that  observed  for 
the other  thymocyte  glycoproteins  TL  (7)  and  Q,a-1  (8). 
The  xenogeneic  monoclonal  antibody,  53.6.72  (10),  which  recognizes  a  different 
structure  on  the  Lyt-2  antigen,  precipitated  molecular  species that  were  identical  in 
size  and  relative  intensity  to  those  observed  using  the  allele-specific  monoclonal 
TABLE  I 
Products of Partial Endo H  Digestion  of the Lyt-2/3  Complex* 
Endo H dose Otg/ml) 
0.0  0.1  0.3  1.0  10.0 
Apparent molecular weights§ 
32  32 
28-29 
24 
X  lO  ,~ 
(32)  (32) 
29 
25  25  25 
24 
20  20  20 
* Lyt-2/3 complexes were immune-precipitated  from a lysate of pulse-labeled B6 thymocytes. 
:~ Faint bands are denoted by parentheses. 
§ Apparent  molecular weights were calibrated  by the migration  of ~4C-methyl labeled standards  (New 
England Nuclear, Boston, MA) on the same 12.5% polyacrylamide gel: bovine serum albumin  (69,000 
tool wt), ovalbumin (46,000 tool wt), carbonic anhydrase (30,000 tool wt), and lactoglobulin A (18,300 
tool wt). 
FIe;.  2.  Two-dimensional  analysis of pulse-labeled Lyt-2.  Lyt-2/3  complexes were  precipitated 
from detergent lysates of thymocytes from B6-Lyt2.1/3. l  (A), B6-Lyt2.1  (B), and B6 (C) mice. In D 
and E, equal amounts of the lysates used in A and C were mixed before precipitation with anti-Lyt- 
2 (D) or normal mouse serum (E). Precipitates were eluted from the S. aureus immunoadsorbent and 
analyzed as described in Materials and Methods. The fluorographs are oriented so that the top of 
the NEPHGE gel (acidic end) is on the left. 2.1, presumptive Lyt-2.1 gene product. 2.2, presumptive 
Lyt-2.2 gene product. Both co-migrate with the 35 K  band shown in Fig.  1. ROTHENBERG AND TRIGLIA  BRIEF  DEFINITIVE REPORT  369 
antibody,  19/178  (data  not  shown).  This  makes  it  unlikely  that  conformational 
changes during processing either obscure or create the determinant recognized by the 
19/178 antibody. 
A  Single  Molecular  Species Controlled by  the  Lyt-2  Locus.  To study  the  product  of 
Lyt-2 gene selectively, we made use of the B6 mouse strains congenic at the Lyt-2 locus 
(6). The molecule specified by Lyt-2 was identified by comparison of the pulse-labeled 
products of B6 (Lyt 2.2; Lyt 3.2), B6-Lyt 2.1 (Lyt 3.2), and B6-Lyt 2.1:3.1 thymocytes, 
using the xenogeneic monoclonal antibody, 53.6.72, to precipitate Lyt-2/3 complexes. 
The  samples  were  fractionated  in  the  first  dimension  by  NEPHGE  and  then  by 
electrophoresis in SDS-polyacrylamide gels (12)  (Fig. 2). In each case, the 35 K  Lyt- 
2/3 component appeared as a single prominent spot. It was symmetrical in form and 
showed no evidence of heterogeneity. There was no size difference between the 35 K 
molecules  made  by  thymocytes of Lyt  2.1  and  Lyt  2.2  genotypes,  but  a  charge 
difference was apparent. The 35 K spot from thymocytes of B6-Lyt 2.1:3.1 or B6-Lyt 
2.1:3.2 mice (Fig. 2, panels A, B) was distinctly more basic than the 35 K  spot from 
B6  (Lyt 2.2/3.2)  thymocytes (Fig.  2, panel  C).  The separation  was  clear when the 
samples  from  panels  A  and  C  were  mixed  before  immune  precipitation  and  gel 
analysis (Fig. 2, panel D). Thus, the isoelectric point of the 35 K  Lyt-2/3 component 
was determined by the allele at the Lyt-2 locus. 
We conclude that each Lyt-2 allele encodes a polypeptide that is homogeneous but 
subject  to rapid  post-translational  processing.  Both the  35- and  38-Kd cell-surface 
molecules  appear  to  be  glycosylated derivatives  of this  initial  product.  Although 
separate T  cell clones may express the 38- and 35-Kd forms of Lyt-2 in different ratios 
(17), this probably reflects differences in the extent of carbohydrate processing rather 
than the activation of different Lyt-2 structural genes. 
Summary 
We investigated the possibility that the Lyt-2 molecules made by uncloned mouse 
T lymphocytes would show variable primary structtlres like those of immunoglobulins. 
Newly synthesized Lyt-2/3 complexes were found to include only two major compo- 
nents, both discrete glycoproteins with apparent molecular weights of 31,000 (31 K) 
and 35,000 (35 K). When products of Lyt-2.1 and Lyt-2.2 thymocytes were compared 
by two-dimensional nonequilibrium pH gradient electrophoresis and sodium dodecyl 
sulfate polyacrylamide gel electrophoresis, the isoelectric points of the 35 K  molecules 
were different; thus, the 35 K  component was likely to be encoded by the Lyt-2 locus 
itself. However, the 35 K  molecules made by any one genotype were homogeneous in 
charge as well as in size. The homogeneity was obscured rapidly by post-translational 
modification.  Most  strikingly,  within  30  min  of initial  synthesis,  these  processing 
events generated the conspicuous array of microheterogeneous products that form the 
"38 K" component of cell-surface Lyt-2/3. 
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